Add to ORKGCopyright © 2015 Iván Carrera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Immunization against amyloid-beta-peptide (
Genetic and environmental factors leading to Alzheimer's disease (AD) converge in a pathogenic pathw...
Copyright © 2013 Etsuro Matsubara et al. This is an open access article distributed under the Creati...
AbstractBackgroundβ-Amyloid peptide (Aβ) oligomers are initial factors used to induce Alzh...
Copyright © 2012 Iván Carrera et al. This is an open access article distributed under the Creative ...
Copyright © 2013 Iván Carrera et al. This is an open access article distributed under the Creative ...
Copyright © 2015 Akira Yano et al. This is an open access article distributed under the Creative Com...
Immunization against amyloid-beta-peptide (Aβ) has been widely investigated as a potential immunothe...
Objective: The aim of this article is to review the role of immunotherapy in the removal of proteins...
The cause of Alzheimer’s disease is still unknown, but the disease is distinctively characterized by...
A key molecule in the pathogenesis of Alzheimer’s disease (AD) is a 42-amino acid isoform of the amy...
The first drugs developed for Alzheimer's disease (AD), anticholinesterase inhibitors (AchEI), incre...
Copyright © 2014 James G. McLarnon.This is an open access article distributed under the Creative Com...
The cause of Alzheimer's disease is still unknown, but the disease is distinctively characterized by...
Previously, our lab was the first to report the use of antigen-sensitized dendritic cells as a vacci...
Alzheimer's disease (AD) is the most common form of dementia in the elderly. AD is characterized by ...
Genetic and environmental factors leading to Alzheimer's disease (AD) converge in a pathogenic pathw...
Copyright © 2013 Etsuro Matsubara et al. This is an open access article distributed under the Creati...
AbstractBackgroundβ-Amyloid peptide (Aβ) oligomers are initial factors used to induce Alzh...
Copyright © 2012 Iván Carrera et al. This is an open access article distributed under the Creative ...
Copyright © 2013 Iván Carrera et al. This is an open access article distributed under the Creative ...
Copyright © 2015 Akira Yano et al. This is an open access article distributed under the Creative Com...
Immunization against amyloid-beta-peptide (Aβ) has been widely investigated as a potential immunothe...
Objective: The aim of this article is to review the role of immunotherapy in the removal of proteins...
The cause of Alzheimer’s disease is still unknown, but the disease is distinctively characterized by...
A key molecule in the pathogenesis of Alzheimer’s disease (AD) is a 42-amino acid isoform of the amy...
The first drugs developed for Alzheimer's disease (AD), anticholinesterase inhibitors (AchEI), incre...
Copyright © 2014 James G. McLarnon.This is an open access article distributed under the Creative Com...
The cause of Alzheimer's disease is still unknown, but the disease is distinctively characterized by...
Previously, our lab was the first to report the use of antigen-sensitized dendritic cells as a vacci...
Alzheimer's disease (AD) is the most common form of dementia in the elderly. AD is characterized by ...
Genetic and environmental factors leading to Alzheimer's disease (AD) converge in a pathogenic pathw...
Copyright © 2013 Etsuro Matsubara et al. This is an open access article distributed under the Creati...
AbstractBackgroundβ-Amyloid peptide (Aβ) oligomers are initial factors used to induce Alzh...